Forefront: HHS Proposes Revised ACA Anti-Discrimination Rule
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Problems viewing this email?
Thursday, July 28, 2022 | The Latest Research, Commentary, And News From Health Affairs
Dear John,

Next week, we'll kick off our event programming in August with a Policy Spotlight event featuring Robert M. Califf, the Biden appointed Commissioner of the Food and Drug Administration (FDA). Join us on August 3 for the one-on-one discussion.
Diabetes-Related Amputations
Nontraumatic lower extremity amputation is a complication of inadequate diabetes control. It is typically preceded by peripheral diabetic neuropathy and peripheral artery disease, which can predispose patients to foot ulcers and infections that lead to limb loss.

In their July issue paper, Hamlet Gasoyan and coauthors perform a systematic review of the literature about disparities in rates or levels of diabetic neuropathy and lower extremity amputation in the US.

The authors examine the demographic factors, barriers to health care, and social determinants of health associated with the rates of both conditions among US adults during the period 2000–2020.

They find that a number of studies report interrelating factors, including patient, provider, and payer variables, associated with diabetic neuropathy and lower extremity amputation.

Furthermore, Gasoyan and coauthors observe race-dependent treatment patterns in the studies they examine.

The authors note that Black patients had a higher likelihood of presenting with peripheral arterial disease undergoing a lower extremity amputation, whereas White patients were more likely to receive a lower extremity arterial revascularization procedure aimed at limb salvage.

Unlock more of our diabetes-related research and read more about the intersections of racism and health on our website by becoming a Health Affairs subscriber today.
Advertisement
Elsewhere At Health Affairs
Today in Health Affairs Forefront, Katie Keith discusses the proposed rule from HHS to significantly revise the agency’s prior interpretation of Section 1557 of the Affordable Care Act, which prohibits discrimination on the basis of race, color, national origin, sex, age, and disability in certain health programs and activities.

Cynthia Ho and Liza Vertinsky discuss how getting a clearer picture of the true costs and risks of drug research and development is a critical starting point in ensuring a more balanced and accurate policy approach toward biomedical innovation.

Health Affairs Forefront provides readers with the latest high value health policy news, commentary, and analysis. With your support we can continue to offer communitywide access to the industry-leading perspectives featured every day on our digital publication.
Daily Digest
Advertise With Health Affairs

Are you looking to get your brand in front of health industry leaders? By advertising with Health Affairs, you can drive traffic to your organization's website and attract the attention of our loyal readership.

Contact our advertising team to learn more and sign up for the Advertiser email list to get exclusive advertising offers every month.
 
Facebook
 
Twitter
 
Linkedin
 
Youtube
 
Email
About Health Affairs

Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.  

Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States

Privacy Policy

To unsubscribe from this email, update your email preferences here
.